FindTrial
Sign In

Comparing the effect of enema in patients with Irritable Bowel Syndrome

A Comparative Clinical Trial on Efficacy of Takravasti and Sangrahi vasti done as Kalavasti in modulating Gut microbiome in Irritable Bowel Syndrome (IBS) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078473
Enrollment
8
Registered
2024-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Sponsors

Vaidyaratnam PS Varier Ayurveda College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants presenting with clinical features of Irritable Bowel syndrome Participants of either sex between the age group of 18-50 years Participants who are fit for Vasti procedure

Exclusion criteria

Exclusion criteria: Participants with known case of Inflammatory bowel disorders which includes Crohn’s disease and Ulcerative Colitis, acute conditions like Cholera, Gastroenteritis Diagnosed case of uncontrolled Diabetes mellitus and hypertension Recent use of Antibiotics less than 3 months Anti-epileptic users Participants taking Iron supplements Alarm features of IBS Age less than 50 years, male gender, weight loss, nocturnal symptoms, family history of Colon Cancer, Anemia, Rectal bleeding

Design outcomes

Primary

MeasureTime frame
Modulation in gut microbiomeTimepoint: Baseline 11th day—

Secondary

MeasureTime frame
IBS Symptom SeverityTimepoint: Baseline & 11th day—

Countries

India

Contacts

Public ContactDr Benil PB

Vaidyaratnam PS Varier Ayurveda College Kottakkal

drbinithaunni@gmail.com9895201635

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026